Pubblicazioni

Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy

2022 - THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

Lia Scribano, Maria; Aratari, Annalisa; Neri, Benedetto; Bezzio, Cristina; Balestrieri, Paola; Baccolini, Valentina; Falasco, Giuliano; Camastra, Caterina; Pantanella, Paolo; Monterubbianesi, Rita; Tullio, Alessandro; Saibeni, Simone; Papi, Claudio; Biancone, Livia; Cosintino, Rocco; Faggiani, Roberto

`CognitiveâBehavioral Treatment of ObsessiveâCompulsive Disorder: The Results of a Naturalistic Outcomes Study

2022 - JOURNAL OF CLINICAL MEDICINE

Gragnani, Andrea; Zaccari, Vittoria; Femia, Giuseppe; Pellegrini, Valerio; Tenore, Katia; Fadda, Stefania; Ines Luppino, Olga; Basile, Barbara; Cosentino, Teresa; Perdighe, Claudia; Romano, Giuseppe; Maria Saliani, Angelo; Mancini, Francesco

Effectiveness as Threat to Constitutional Systems

2022 - Encyclopedia of Contemporary Constitutionalism

Marra, Piero; Galatola, Irene

Masculinity and Leadership Effectiveness (Self-)Perceptions: The Case of Lesbian Leaders

2022 - INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH

Shamloo, S. E.; De Cristofaro, V.; Pellegrini, V.; Salvati, M.

Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)

2022 - BRITISH JOURNAL OF HAEMATOLOGY

Breccia, Massimo; Olimpieri, Pier Paolo; Celant, Simone; Olimpieri, Odoardo; Pane, Fabrizio; Iurlo, Alessandra; Summa, Valentina; Corradini, Paolo; Russo, Pierluigi

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naÃ¯ve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)

2022 - ACTA DIABETOLOGICA

Paolo Fadini, Gian; Buzzetti, Raffaella; Nicolucci, Antonio; Larosa, Monica; CATALANO ROSSI DANIELLI, MARIA CHIARA; Cucinotta, Domenico; Study Group, RESTORE-2

Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1Â° generation basal insulins

2022 - NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Buzzetti, R.; Fadini, G. P.; Nicolucci, A.; Larosa, M.; Rossi, M. C.; Cucinotta, D.